Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

John H. Hammergren net worth and biography

John Hammergren Biography and Net Worth

Chairman of McKesson

American Hospital Supply Corporation, Baxter Healthcare Corporation, and Lyphomed, 1981–1991, series of management positions; Kendall Healthcare Products, 1991–1995, president of medical-surgical division; McKesson Corporation, 1996–1998, president of McKesson Health Systems; 1999, executive vice president as well as president and chief executive officer of supply management; 1999–2001, president and co–chief executive officer; 2001–, president and chief executive officer; 2002–, president, chairman, and chief executive officer.

John H. Hammergren was exalted as "squeaky clean with a knack for complexity" in an era following not-so-squeaky-clean executives of companies such as Enron, Tyco, World-Com, and even former executives of his own company. Hammergren was president, chairman, and CEO of McKesson Corporation, the country's largest supplier of software solutions, technological innovations, and comprehensive services to the healthcare industry and a wholesale distributor of prescription drugs. He took over following McKesson's January 1999 scandal-ridden acquisition of HBOC in which accounting irregularities inflated HBOC's revenues. Although initially Hammergren doubted he could repair the damage, he did so. He also took on the larger task of restoring confidence in company leadership: "The reputation of Corporate America has been sullied and the reputation of CEOs has been tarnished and it makes the complexity of our job even greater"

What is John H. Hammergren's net worth?: The estimated net worth of John H. Hammergren is at least $86.60 million as of September 29th, 2017. Mr. Hammergren owns 165,000 shares of McKesson stock worth more than $86,596,950 as of April 20th. This net worth approximation does not reflect any other investments that Mr. Hammergren may own. Learn More about John H. Hammergren's net worth.
How do I contact John H. Hammergren?: The corporate mailing address for Mr. Hammergren and other McKesson executives is 6555 STATE HWY 161, IRVING TX, 75039. McKesson can also be reached via phone at (972) 446-4800 and via email at [email protected]. Learn More on John H. Hammergren's contact information.
Has John H. Hammergren been buying or selling shares of McKesson?: John H. Hammergren has not been actively trading shares of McKesson in the last ninety days. Learn More on John H. Hammergren's trading history.
Who are McKesson's active insiders?: McKesson's insider roster includes Nancy Avila (EVP), James Beer (CFO), Kevin Emerson (CAO), Tracy Faber (EVP), Nancy Flores (EVP), John Hammergren (Chairman), Marie Knowles (Director), Erin Lampert (SVP), Sundeep Reddy (SVP), Thomas Rodgers (EVP), Lori Schechter (EVP), LeAnn Smith (EVP), Brian Tyler (CEO), Brian Tyler (CEO), and Britt Vitalone (CFO). Learn More on McKesson's active insiders.
Are insiders buying or selling shares of McKesson?: During the last twelve months, insiders at the sold shares 20 times. They sold a total of 130,252 shares worth more than $56,328,345.62. The most recent insider tranaction occured on March, 15th when CEO Brian S Tyler sold 3,473 shares worth more than $1,821,762.15. Insiders at McKesson own 0.2% of the company. Learn More about insider trades at McKesson.
Information on this page was last updated on 3/15/2024.

John H. Hammergren Insider Trading History at McKesson

John H. Hammergren Buying and Selling Activity at McKesson

McKesson Company Overview

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Today's Range

Now: $524.83

$517.01

$525.83

50 Day Range

MA: $524.91

$494.48

$540.10

2 Week Range

Now: $524.83

$352.34

$543.00

Volume

645,368 shs

Average Volume

688,808 shs

Market Capitalization

$68.97 billion

P/E Ratio

23.78

Dividend Yield

0.47%

Beta

0.45